Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
758.43-
QQQ
707.201.27%
BTC/USD
76801.161.8912%
DIA
522.760.25%
GLD
398.43-
TLT
80.970.93%

Abbott Laboratories (ABT) Stock Price, Quote, News & History

ABTNYSE
Trade with Public
Trade with Public
$105.10
-0.42-0.4%
Last update: Sep 9, 4:31 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipDividendsCompareOptionsStock Report

Abbott Laboratories (ABT) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$105.23
Volume / Avg.
492.00 / 11.13M
Day Range
- - -
52 Wk Range
81.97 - 137.49
Market Cap
$181.86B
P/E Ratio
34.06
Dividend Yield
2.39%
Exchange
NYSE
RSI
39
Short Interest
1.32%
Days to Cover
2.86

Recent Abbott Laboratories News

FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
Vandana Singh

Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation

Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving its specialty preterm infant formulas.
Vandana Singh

Congressman Ditches Blue Chip Stocks for Municipal Bonds: Here Are the Sales

A congressman reported selling stocks recently, while also investing in a municipal bond.
Chris Katje

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.
Avi Kapoor

Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, and SBAC were upgraded or downgraded.
Avi Kapoor
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
9.90B
Investing Cash Flow (TTM)
-22.37B
Financing Cash Flow (TTM)
10.64B
Free Cash Flow (TTM)
7.82B
Capital Expenditure (TTM)
-2.08B
Net Change in Cash (TTM)
-1.82B

Analyst Trends and Forecast

1
May
1
Jun
11
Jul
3
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$209.09B
PE Ratio (TTM)
34.06
PE Ratio (FWD)
17.39
PEG Ratio (TTM)
1.93
PS Ratio (TTM)
3.94
PB Ratio (TTM)
3.56
Earnings Yield % (TTM)
2.94%
Earnings Yield % (FWD)
5.75%
EV / EBITDA (TTM)
17.84
Price / EBITDA (TTM)
15.67
Price / Free Cash Flow (TTM)
23.48
Book Value / Share
$29.54

Company Debt

Total Debt
$32.61B
LT Debt
$29.60B
LT Debt Issuance (TTM)
$19.83B
LT Debt Repayment (TTM)
-$3.32B
Total Cash
$5.10B
Debt to Equity
0.64
Issuance of Debt (TTM)
$16.51B
Repayment of Debt (TTM)
-$3.32B

Key Statistics

Open
-
Close
$105.23
Volume / Avg.
492.00 / 11.13M
Day Range
- - -
52 Wk Range
81.97 - 137.49
Market Cap
$181.86B
P/E Ratio
34.06
Dividend Yield
2.39%
Exchange
NYSE
RSI
39
Short Interest
1.32%
Days to Cover
2.86

About

Sector
Health Care
Industry
Health Care Equipment & Supplies
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neu...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Abbott Laboratories (ABT) stock?

A

You can purchase shares of Abbott Laboratories (NYSE:ABT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abbott Laboratories (ABT) competitors?

Q

What is the forecast, or price target, for Abbott Laboratories (ABT) stock?

A

Abbott Laboratories has a consensus price target of $129.48.

Q

What is the current price for Abbott Laboratories (ABT)?

A

The stock price for Abbott Laboratories (NYSE: ABT) is $105.1 last updated September 9, 2026 at 4:31 PM EDT.

Q

Does Abbott Laboratories (ABT) pay a dividend?

A

There are no upcoming dividends for Abbott Laboratories.

Q

When is Abbott Laboratories (NYSE:ABT) reporting earnings?

A

Abbott Laboratories does not have any upcoming earnings scheduled.

Q

Is Abbott Laboratories (ABT) going to split?

A

There is no upcoming split for Abbott Laboratories.

Q

What sector and industry does Abbott Laboratories (ABT) operate in?

A

Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved